Long-term outcomes of adults with first-relapsed/refractory systemic anaplastic large-cell lymphoma in the pre-brentuximab vedotin era: A LYSA/SFGM-TC study.
暂无分享,去创建一个
P. Gaulard | H. Tilly | C. Haioun | O. Tournilhac | R. Delarue | J. Brière | D. Sibon | E. Bachy | L. Lamant | C. Laurent | A. Sonet | Alexandre Morel | M. Loschi | S. Amorim